Evaluation of Aerosol in a Dental Clinic
Phase 4
Recruiting
- Conditions
- Covid19
- Interventions
- Device: High volume evacuation (HVE)Device: Extraoral vacuum aspirator (EVA)Device: External evacuation device (EED)Drug: Hydrogen Peroxide
- Registration Number
- NCT04659928
- Lead Sponsor
- The University of Texas Health Science Center, Houston
- Brief Summary
The purpose of this study is to evaluate the effectiveness of external evacuation units and mouth rinses during aerosol generating procedures in a dental clinic and to determine the risk level to the dental practitioners during aerosol generating procedures.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- prepping natural teeth at the appointment
- at least an hour long procedure
- procedure will be the first one in the morning
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description HVE suction and extraoral vacuum aspirator (EVA) and hydrogen peroxide Extraoral vacuum aspirator (EVA) - HVE suction and external evacuation device (EED) and hydrogen peroxide External evacuation device (EED) - High volume evacuation (HVE) suction only and hydrogen peroxide High volume evacuation (HVE) - High volume evacuation (HVE) suction only and hydrogen peroxide Hydrogen Peroxide - HVE suction and extraoral vacuum aspirator (EVA) and hydrogen peroxide High volume evacuation (HVE) - HVE suction and external evacuation device (EED) and hydrogen peroxide High volume evacuation (HVE) - HVE suction and extraoral vacuum aspirator (EVA) and hydrogen peroxide Hydrogen Peroxide - HVE suction and external evacuation device (EED) and hydrogen peroxide Hydrogen Peroxide -
- Primary Outcome Measures
Name Time Method Number of bacterial colony forming units (CFUs) . 24 to 48 hours after treatment
- Secondary Outcome Measures
Name Time Method Change in number of CFUs Baseline,1 hour after treatment
Trial Locations
- Locations (1)
The University of Texas Health Science Center at Houston
πΊπΈHouston, Texas, United States